How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 101–200 of 1,008
Mithaiwala, M. N., Santana-Coelho, D., Porter, G. A., & O’Connor, J. C. (2021) · Cells · doi:10.3390/cells10061548 · Cited by 190
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
“Genetic studies further support the role of immunity and inflammation in conditions such as AD, PD, and amyotrophic lateral sclerosis (ALS).”
BackgroundJian, M., Kwan, J. S.-C., Bunting, M., Ng, R. C.-L., & Chan, K. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1492-6 · Cited by 188
“Increasing evidence suggests that neuroinflammation mediated by glial cells, including both microglia and astrocytes, contributes to AD pathogenesis [11].”
BackgroundChen, H.-L., Chen, P.-C., Lu, C.-H., Tsai, N.-W., Yu, C.-C., Chou, K.-H., Lai, Y.-R., Taoka, T., & Lin, W.-C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4034509 · Cited by 184
“Abnormal increased accumulation of misfolding proteins, together with blood-brain barrier (BBB) disruption and neuroinflammation, is related in a vicious cycle and might highly associate with the development of PD and subsequent disease progression [3].”
BackgroundMicroglia regulate synaptic development and plasticity
Andoh, M., & Koyama, R. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22814 · Cited by 184
“…by microglia [Color figure can be viewed at wileyonlinelibrary.com] 580 | ANDOH AND KOYAMA inflammation, but increased expression of inflammatory molecules alone should not be considered inflammation in itself if the inflammatory response is not verified (Graeber et al., 2011; Ransohoff, 2016).”
BackgroundVinall, J., Pavlova, M., Asmundson, G., Rasic, N., & Noel, M. (2016) · Children · doi:10.3390/children3040040 · Cited by 183
“, autoimmune diseases, aging) [123,124] and may arise from acute immune challenges [125].”
BackgroundThe involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Feng, Y.-S., Tan, Z.-X., Wu, L.-Y., Dong, F., & Zhang, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101192 · Cited by 184
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
(2024) · aging and disease · doi:10.14336/ad.2023.0608 · Cited by 183
“Moreover, some studies suggest that inflammation occurs early in the disease process and contributes to the development of pathology, while others suggest that it is a secondary response to neuronal damage [52].”
BackgroundAxonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
“, 2009), it has been difficult to define the role of inflammation in neurodegeneration (Ransohoff, 2016).”
BackgroundGut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177
“Recent investigations have suggested that gut dysbiosis is linked to aberrant immune responses, which not only increases intestinal inflammation but also increases microglial activation and neuroinflammation (97, 98), which are central events in the pathogenesis of PD (99).”
BackgroundNovel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
Van Bulck, M., Sierra-Magro, A., Alarcon-Gil, J., Perez-Castillo, A., & Morales-Garcia, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030719 · Cited by 178
Zimmerman, B., Rypma, B., Gratton, G., & Fabiani, M. (2021) · Psychophysiology · doi:10.1111/psyp.13796 · Cited by 179
“…inflammation contributes to the pathology of many nervous system diseases, including those common in aging (Calcia et al., 2016; Freeman & Ting, 2016; Iadecola & Anrather, 2011; Martini & Willison, 2016; McGeer & McGeer, 2013; Najjar et al., 2013; Ransohoff, 2016; Skaper et al., 2018).”
BackgroundThurgur, H., & Pinteaux, E. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.046 · Cited by 176
Circadian and sleep dysfunction in Alzheimer’s disease
Uddin, M. S., Tewari, D., Mamun, A. A., Kabir, M. T., Niaz, K., Wahed, M. I. I., Barreto, G. E., & Ashraf, G. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101046 · Cited by 173
Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
Lee, Y., Lee, S., Chang, S.-C., & Lee, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01133-0 · Cited by 167
Li, C., Wang, N., Zheng, G., & Yang, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c14818 · Cited by 165
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Andronie-Cioara, F. L., Ardelean, A. I., Nistor-Cseppento, C. D., Jurcau, A., Jurcau, M. C., Pascalau, N., & Marcu, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031869 · Cited by 164
“Aside from the heavy burden on healthcare and social systems as well as on families posed by Alzheimer’s disease (AD), it also robs affected individuals of the attributes that make long lives worth living, such as memories, feelings, thinking, or the ability to make decisions [3].”
BackgroundSalidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis
Zhang, X., Zhang, Y., Li, R., Zhu, L., Fu, B., & Yan, T. (2020) · Aging · doi:10.18632/aging.103215 · Cited by 163
“, has a wide spectrum of pharmacological effects, such as anti-inflammatory [27], anti-oxidant [30], anti-depressive [31], antiradiation [32], anti-cancer [33] and cardio-protective [34].”
BackgroundPathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Cruz-Haces, M., Tang, J., Acosta, G., Fernandez, J., & Shi, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0088-2 · Cited by 161
“Pathological mechanisms of neurodegenerative diseases Despite divergent clinical presentation, AD, PD, and ALS have several common characteristics [56].”
BackgroundWhen encephalitogenic T cells collaborate with microglia in multiple sclerosis
Dong, Y., & Yong, V. W. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0253-6 · Cited by 160
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
Sambra, V., Echeverría, F., Valenzuela, A., Chouinard‐Watkins, R., & Valenzuela, R. (2021) · Nutrients · doi:10.3390/nu13030986 · Cited by 175
Impact of dietary fats on brain functions
Chianese, R., Coccurello, R., Viggiano, A., Scafuro, M., Fiore, M., Coppola, G., Operto, F. F., Fasano, S., Laye, S., Pierantoni, R., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171017102547 · Cited by 159
“In addition, aging and neurodegenerative diseases are accompanied by increased proinflammatory factors such as cytokines and reactive oxygen species (ROS) production, which participate to neuronal death, neuropathological processes and promote cognitive deficit [23, 251].”
BackgroundBiallelic Mutations in MYORG Cause Autosomal Recessive Primary Familial Brain Calcification
Yao, X.-P., Cheng, X., Wang, C., Zhao, M., Guo, X.-X., Su, H.-Z., Lai, L.-L., Zou, X.-H., Chen, X.-J., Zhao, Y., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.037 · Cited by 158
Priming of microglia with IFN-γ slows neuronal gamma oscillations in situ
Ta, T.-T., Dikmen, H. O., Schilling, S., Chausse, B., Lewen, A., Hollnagel, J.-O., & Kann, O. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1813562116 · Cited by 156
Chung, H.-Y., Wickel, J., Hahn, N., Mein, N., Schwarzbrunn, M., Koch, P., Ceanga, M., Haselmann, H., Baade-Büttner, C., von Stackelberg, N., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq7806 · Cited by 156
Burtscher, J., Millet, G. P., Place, N., Kayser, B., & Zanou, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126479 · Cited by 170
“The convergence of pathogenic mechanisms in many neurodegenerative diseases that include mitochondrial dysfunction and oxidative stress [12,13], protein aggregation [14,15], inflammation [16], and brain regional vulnerabilities [17] also highlight the relevance of the related influences of muscle–brain crosstalk for o…”
BackgroundMicroglia-Specific Metabolic Changes in Neurodegeneration
Aldana, B. I. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.03.006 · Cited by 154
“Functional neuroimaging studies including positron-emission tomography (PET) analyses using fluoro-deoxyglucose uptake into brain cells have shown reduced regional glucose utilization in the brain of patients suffering from AD, PD, ALS, and HD [16 – 18 , 60 – Notably, the studies summarized below are representative ev…”
BackgroundInfluentialPET Imaging of Neuroinflammation in Alzheimer’s Disease
Zhou, R., Ji, B., Kong, Y., Qin, L., Ren, W., Guan, Y., & Ni, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739130 · Cited by 152
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 164
“Neuroinflammation in diseases, such as PD, AD, and ALS, is characterized by a reactive morphology of glial cells and increased levels of inflammatory mediators in the parenchyma (Ransohoff, 2016).”
BackgroundP2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology
Stokes, L., Layhadi, J. A., Bibic, L., Dhuna, K., & Fountain, S. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00291 · Cited by 152
“Neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease are associated with neuroinflammation (Ransohoff, 2016) and microglia appear to be central (Saijo and Glass, 2011; Joers et al.”
BackgroundKann, O., Almouhanna, F., & Chausse, B. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.10.007 · Cited by 150
The immunological response to traumatic brain injury
Needham, E. J., Helmy, A., Zanier, E. R., Jones, J. L., Coles, A. J., & Menon, D. K. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.04.005 · Cited by 150
Single-Cell RNA Sequencing: Unraveling the Brain One Cell at a Time
Ofengeim, D., Giagtzoglou, N., Huh, D., Zou, C., & Yuan, J. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.006 · Cited by 149
“These studies are particularly relevant because an emerging concept in the field of neurodegeneration includes the role of immune dysfunction in driving disease pathology [73] [74].”
BackgroundIkram, M. A., Park, T. J., Ali, T., & Kim, M. O. (2020) · Antioxidants · doi:10.3390/antiox9090902 · Cited by 170
The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration
Tu, D., Gao, Y., Yang, R., Guan, T., Hong, J., & Gao, H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1659-1 · Cited by 161
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Staff, N. P., Jones, D. T., & Singer, W. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.001 · Cited by 150
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
“which can be beneficial if the response clears the site of injury or infection but detrimental if this reaction further damages the surrounding tissue (Ransohoff, 2016).”
BackgroundZhang, J. C., Zhang, X., Wang, C., Li, F., Qiao, Z., Zeng, L., Wang, Z., Liu, H., Ding, J., & Yang, H. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000604 · Cited by 150
Trained immunity: General and emerging concepts
Vuscan, P., Kischkel, B., Joosten, L. A. B., & Netea, M. G. (2024) · Immunological Reviews · doi:10.1111/imr.13326 · Cited by 175
Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
Kouli, A., Horne, C. B., & Williams-Gray, C. H. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.042 · Cited by 143
The fate of the brain cholinergic neurons in neurodegenerative diseases
Pepeu, G., & Giovannini, M. G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.06.023 · Cited by 157
“The neuroinflammation involvement in AD pathogenesis was suggested more than twenty years ago and the large evidence has been recently reviewed (McGeer et al, 2016) as well as its contribution to neurodegeneration (Ransohoff, 2016).”
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading
Jain, N., Lewis, C. A., Ulrich, J. D., & Holtzman, D. M. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220654 · Cited by 146
“In addition to deposition of protein aggregates, neuroinflammation that includes reactive microglia is a common feature of AD (Ransohoff, 2016).”
BackgroundMonoacylglycerol lipase (MAGL) as a promising therapeutic target
Gil-Ordóñez, A., Martín‐Fontecha, M., Ortega‐Gutiérrez, S., & López-Rodríguez, M. L. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.036 · Cited by 158
Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration
Puigdellívol, M., Allendorf, D. H., & Brown, G. C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00162 · Cited by 141
“Thus, chronic neuroinflammation may contribute to neurodegeneration (Ransohoff, 2016; Nichols et al., 2019).”
BackgroundNEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found?
An, H., Williams, N. G., & Shelkovnikova, T. A. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.11.003 · Cited by 162
“central disease mechanisms in NDDs, as reviewed extensively elsewhere [75].”
BackgroundCD38 in Neurodegeneration and Neuroinflammation
Guerreiro, S., Privat, A.-L., Bressac, L., & Toulorge, D. (2020) · Cells · doi:10.3390/cells9020471 · Cited by 141
“Furthermore, non-cell-autonomous processes like neuroinflammation are also heavily suspected to participate in neurodegeneration [2].”
BackgroundPolyphenols and neuroprotection: therapeutic implications for cognitive decline
Caruso, G., Torrisi, S. A., Mogavero, M. P., Currenti, W., Castellano, S., Godos, J., Ferri, R., Galvano, F., Leggio, G. M., Grosso, G., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108013 · Cited by 140
Zhang, L., Silva, T. C., Young, J. I., Gomez, L., Schmidt, M. A., Hamilton-Nelson, K. L., Kunkle, B. W., Chen, X., Martin, E. R., & Wang, L. (2020) · Nature Communications · doi:10.1038/s41467-020-19791-w · Cited by 139
Krishnan, A., Kocab, A. J., Zacks, D. N., Marshak-Rothstein, A., & Gregory-Ksander, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1576-3 · Cited by 136
Yang, P., Sheng, D., Guo, Q., Wang, P., Xu, S., Qian, K., Li, Y., Cheng, Y., Wang, L., Lu, W., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119844 · Cited by 137
Liu, P., Zhang, T., Chen, Q., Li, C., Chu, Y., Guo, Q., Zhang, Y., Zhou, W., Chen, H., Zhou, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100746 · Cited by 135
Brain macrophage development, diversity and dysregulation in health and disease
Silvin, A., Qian, J., & Ginhoux, F. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01053-6 · Cited by 137
Kim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136
“Inflammation, oxidative stress, and deficits in neurotransmitters are the common features of the biochemical switch that ultimately results in the activation of the apoptotic pathways that lead to neuronal cell dysfunction and death and eventually to the neurological disorder.(2,25) Interestingly, these pathological e…”
BackgroundYin, N., Zhao, Y., Liu, C., Yang, Y., Wang, Z., Yu, W., Zhang, K., Zhang, Z., Liu, J., Zhang, Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202201322 · Cited by 134
NG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis
Zhang, S.-Z., Wang, Q.-Q., Yang, Q.-Q., Gu, H.-Y., Yin, Y.-Q., Li, Y.-D., Hou, J.-C., Chen, R., Sun, Q.-Q., Sun, Y.-F., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1439-x · Cited by 135
“An excessive inflammatory process unavoidably causes normal tissue damages and functional compromises for the host [3].”
BackgroundThe renin–angiotensin system: a possible new target for depression
Vian, J., Pereira, C., Chavarria, V., Köhler, C., Stubbs, B., Quevedo, J., Kim, S.-W., Carvalho, A. F., Berk, M., & Fernandes, B. S. (2017) · BMC Medicine · doi:10.1186/s12916-017-0916-3 · Cited by 134
Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 152
“For example, the release of CX3CL activates the Nrf2 signaling in microglial cells [116,120].”
BackgroundInfluential“Hypothalamic Microinflammation” Paradigm in Aging and Metabolic Diseases
Cai, D., & Khor, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.021 · Cited by 131
Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2017) · The Neuroscientist · doi:10.1177/1073858416687249 · Cited by 138
“…to neurodegenerative diseases (Amor and Woodruffe 2014; Appel and others 2011; Cunningham, 2013; Harcha and others 2015; Medeiros and LaFerla 2013; Ransohoff 2016; Silver and Curley 2013) and neuropsychiatric disorders (Prinz and Priller 2014; Theoharides and others 2015; Wohleb and others 2016).”
Götzl, J. K., Brendel, M., Werner, G., Parhizkar, S., Sebastian Monasor, L., Kleinberger, G., Colombo, A., Deussing, M., Wagner, M., Winkelmann, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809711 · Cited by 118
“While for a long time researchers distinguished only two distinct stages of microglia, the M1 and the M2 phenotype, recent evidence strongly indicates that a multitude of functionally diverse microglial populations exists in a dynamic equilibrium (Ransohoff, 2016; Keren-Shaul et al, 2017; Krasemann et al, 2017).”
BackgroundAutophagy and Parkinson’s Disease
Lu, J., Wu, M., & Yue, Z. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-4272-5_2 · Cited by 131
Parhizkar, S., Gent, G., Chen, Y., Rensing, N. R., Gratuze, M., Strout, G. W., Sviben, S., Tycksen, E., Zhang, Q., Erdmann-Gilmore, P., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade6285 · Cited by 156
“Microglial reactivity is an important response to brain injury or protein aggregates such as Aβ plaques, which elicits a neuroinflammatory response by promoting an increase in cytokines, complement proteins, interleukins, and chemokines presumably in an attempt to recover from the diseased state (23, 24).”
BackgroundObrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2020) · Antioxidants · doi:10.3390/antiox9090901 · Cited by 147
“If these cells cannot eliminate a toxic insult, they remain reactive and continue to recruit astrocytes and oligodendrocytes causing an ongoing inflammatory process [19].”
BackgroundNeuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
Kasatkina, L. A., Rittchen, S., & Sturm, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115431 · Cited by 142
“While neuroinflammation in MS involves infiltration of peripheral immune cells, breakdown of the BBB, and activation of CNS-resident glial cells, neuroinflammation in the other neurodegenerative diseases is more restricted to glial cell activation and inflammatory reactions in the parenchyma [201].”
BackgroundNeurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy
Vasić, V., Barth, K., & Schmidt, M. H. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174272 · Cited by 142
Wang, H., Yang, F., Zhang, S., Xin, R., & Sun, Y. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00213-7 · Cited by 126
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
“It is also an early and common hallmark of neurodegenerative diseases (Ransohoff, 2016).”
BackgroundResultMai, C.-L., Tan, Z., Xu, Y.-N., Zhang, J.-J., Huang, Z.-H., Wang, D., Zhang, H., Gui, W.-S., Zhang, J., Lin, Z.-J., et al. (2021) · Theranostics · doi:10.7150/thno.44364 · Cited by 123
“Multiple animal models of cognitive impairment are characterized by sustained activation of microglia and/or astrocytes and overproduction of proinflammatory cytokines, impairing neurogenesis and synaptic plasticity [5, 12-15].”
BackgroundProtein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Vieira, M. N. N., Lyra e Silva, N. M., Ferreira, S. T., & De Felice, F. G. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00007 · Cited by 121
“These lines of evidence support dampening microglia-mediated neuroinflammation as an attractive therapeutic approach in AD (Ransohoff, 2016; Santos et al., 2016; Wes et al., 2016).”
BackgroundThe Role of Microglia in the Spread of Tau: Relevance for Tauopathies
Perea, J. R., Llorens-Martín, M., Ávila, J., & Bolós, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00172 · Cited by 122
Jensen, C. S., Bahl, J. M., Østergaard, L. B., Høgh, P., Wermuth, L., Heslegrave, A., Zetterberg, H., Heegaard, N. H. H., Hasselbalch, S. G., & Simonsen, A. H. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.04.003 · Cited by 121
“Inflammation has been established as an important contributor to AD pathology (Ransohoff, 2016).”
Baxter, P. S., Dando, O., Emelianova, K., He, X., McKay, S., Hardingham, G. E., & Qiu, J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108882 · Cited by 122
“…of microglia function contributes to or drives the pathogenesis of certain neurodevelopmental and psychiatric diseases such as autism and schizophrenia, as well as neurodegenerative diseases, including Alzheimer’s disease (AD) (Perry and Holmes, 2014; Ransohoff, 2016; Salter and Stevens, 2017).”
BackgroundIs Triclosan a neurotoxic agent?
Ruszkiewicz, J. A., Li, S., Rodriguez, M. B., & Aschner, M. (2017) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2017.1281181 · Cited by 127
Mitophagy and cGAS–STING crosstalk in neuroinflammation
Zhou, X., Wang, J., Yu, L., Qiao, G., Qin, D., Yuen-Kwan Law, B., Ren, F., Wu, J., & Wu, A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.012 · Cited by 131
You, R., Ho, J. Y. S., Hung, C. H.-L., Liu, Y., Huang, C.-X., Chan, H., Ho, S., Lui, S.-Y., Li, H., & Chang, R. C. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0263-3 · Cited by 123
“The key players in this process are the activated microglia [24], which proliferate and express/secrete increased levels of pro-inflammatory cytokines, such as interleukin (IL)-1β and IL-6, as well as other inflammatory mediators, such as cyclooxygenase 2 (COX-2) [25].”
BackgroundInflammatory Events Following Subarachnoid Hemorrhage (SAH)
Schneider, U. C., Xu, R., & Vajkoczy, P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180412110919 · Cited by 129
“Meticulous understanding of beneficial and detrimental effects of microglia under certain pathological conditions is crucial to further advance our knowledge on this very special kind of cell within the brain [26, 27, 32, 36, 81-84].”
BackgroundAnti-inflammatory and antioxidant mechanisms of urolithin B in activated microglia
Lee, G., Park, J., Lee, E.-J., Ahn, J., & Kim, H.-S. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.032 · Cited by 125
Gut microbiota modulation accounts for the neuroprotective properties of anthocyanins
Marques, C., Fernandes, I., Meireles, M., Faria, A., Spencer, J. P. E., Mateus, N., & Calhau, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29744-5 · Cited by 117
Liang, H., Chen, A., Lai, X., Liu, J., Wu, J., Kang, Y., Wang, X., & Shao, L. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0274-0 · Cited by 125
“Furthermore, neuropathologists have found that glial cells, including astrocytes and microglia, are activated in each of these disorders, accompanied by low-to-moderate levels of inflammatory mediators in the parenchyma [16].”
BackgroundNADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury
Ma, M. W., Wang, J., Dhandapani, K. M., & Brann, D. W. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6057609 · Cited by 117
NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?
Sorce, S., Stocker, R., Seredenina, T., Holmdahl, R., Aguzzi, A., Chio, A., Depaulis, A., Heitz, F., Olofsson, P., Olsson, T., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.006 · Cited by 115
“Indeed, microglia can exert both detrimental and protective functions, depending on the particular pathological context [14].”
BackgroundInfluentialAminophospholipids are signal-transducing TREM2 ligands on apoptotic cells
Shirotani, K., Hori, Y., Yoshizaki, R., Higuchi, E., Colonna, M., Saito, T., Hashimoto, S., Saito, T., Saido, T. C., & Iwata, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-43535-6 · Cited by 116
Single-nucleus transcriptomic landscape of primate hippocampal aging
Zhang, H., Li, J., Ren, J., Sun, S., Ma, S., Zhang, W., Yu, Y., Cai, Y., Yan, K., Li, W., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00852-9 · Cited by 114
“In addition to intrinsic changes, direct cell-to-cell contacts also modulate neurogenesis during aging (Ransohoff, 2016; Leng and Edison, 2021), which may precede the decline in neurogenesis.”
BackgroundLiu, Y., Zhao, C., Meng, J., Li, N., Xu, Z., Liu, X., & Hou, S. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.108939 · Cited by 115
Perez, B. A., Shutterly, A., Chan, Y. K., Byrne, B. J., & Corti, M. (2020) · Brain Sciences · doi:10.3390/brainsci10020119 · Cited by 112
“Neuroinflammation is already a feature of many neurodegenerative diseases such as AD, Parkinson’s disease (PD), and multiple sclerosis (MS) [27].”
BackgroundSorrenti, V., Contarini, G., Sut, S., Dall’Acqua, S., Confortin, F., Pagetta, A., Giusti, P., & Zusso, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00183 · Cited by 113
“LPS can affect memory and cognitive functions in different behavioral paradigms in both rats and mice (Reichenberg et al., 2001; Jacewicz et al., 2009; Ownby, 2010; Bossù et al., 2012; Kawamoto et al., 2013; Lee Y.J. et al., 2013; Zhang et al., 2015).”
BackgroundCircadian Rhythm and Alzheimer’s Disease
Homolak, J., Mudrovčić, M., Vukić, B., & Toljan, K. (2018) · Medical Sciences · doi:10.3390/medsci6030052 · Cited by 138
“Peripheral stimuli may trigger a central neuroinflammatory response directly via infection or tissue damage and subsequent pathogen-associated molecular protein (PAMP) or damage-associated molecular protein (DAMP) induced immune cascades [67,76].”
BackgroundHan, R., Liu, Z., Sun, N., Liu, S., Li, L., Shen, Y., Xiu, J., & Xu, Q. (2018) · Aging and Disease · doi:10.14336/ad.2018.0707 · Cited by 124
“Activation of microglia is a central event and driving force in the pathogenesis of neuroinflammation [48, 49].”
BackgroundTodd, N., Angolano, C., Ferran, C., Devor, A., Borsook, D., & McDannold, N. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.040 · Cited by 112
“Clearance of the amyloid-β and Tau proteins—Persistent neuroinflammation can be harmful to the brain, and indeed is a hallmark of many neurodegenerative diseases (46).”
BackgroundRoles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano‐Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 119
Baldacci, F., Lista, S., Cavedo, E., Bonuccelli, U., & Hampel, H. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304217 · Cited by 113
“Neuroinflammation is a key mechanism in the pathophysiology of primary neurodegenerative diseases [1] – which presents a continuous genetic, biochemical, pathological and clinical spectrum and can collectively be conceptualized as protein misfolding disorders or proteinopathies of the central nervous system (CNS).”
Backgrounddos Reis, R. S., Sant, S., Keeney, H., Wagner, M. C. E., & Ayyavoo, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-72214-0 · Cited by 110
Que, R., Zheng, J., Chang, Z., Zhang, W., Li, H., Xie, Z., Huang, Z., Wang, H., Xu, J., Jin, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.794770 · Cited by 115
“The over-activation of microglia and the release of proinflammatory cytokines play important roles in neurodegeneration in individuals with PD (14).”
BackgroundKaczmarczyk, R., Tejera, D., Simon, B. J., & Heneka, M. T. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14284 · Cited by 110
Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer’s Disease
Paouri, E., & Georgopoulos, S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190321154618 · Cited by 110
Zhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109
Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis
Vu, L. T., & Bowser, R. P. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0503-x · Cited by 122
Gaetani, L., Paolini Paoletti, F., Bellomo, G., Mancini, A., Simoni, S., Di Filippo, M., & Parnetti, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.011 · Cited by 108
Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 127
“The discovery of chronic activation of the immune response in the central nervous system (CNS) and elevated levels of inflammatory factors in patients and animal models suggest that neuroinflammation plays a remarkable role in the complex pathogenesis of neurodegenerative diseases [12].”
BackgroundTondo, G., Iaccarino, L., Caminiti, S. P., Presotto, L., Santangelo, R., Iannaccone, S., Magnani, G., & Perani, D. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00619-0 · Cited by 107
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.